|
|
|
|
|
|
|
|
|
|
|
12.11.25 - 23:00
|
Cross Country Healthcare Announces Third Quarter 2025 Financial Results (Business Wire)
|
|
|
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the Company) (Nasdaq: CCRN) today announced financial results for its third quarter ended September 30, 2025.
Selected Financial Information:
Variance
Variance
Q3 2025 vs
Q3 2025 vs
Dollars are in thousands, except per share amounts
Q3 2025
Q3 2024
Q2 2025
Revenue
$
250,052
(21
)%
(9
)%
Gross profit margin*
20.4
%
—
bps
—
bps
Net loss attributable to common stockholders
$
(4,774
)
(287
)%
28
%
Diluted EPS
$
(0.15
)
$
(0.23
)
$
0.05
Adjusted EBITDA*
$
6,524
(37
)%
(14
)%
Adjusted EBITDA margin*
2.6
%
(70
)bps
(20
)bps
Adjusted EPS*
$
0.03
$
(0.09
)
$
0.04
Cash flows provided by operations
$
20,114
169
%
377
%
* Represents amounts that are not calculated in accordance with U.S. generally accepted accounting principles (GAAP) and are referred to as non-GAAP measures. Please refer to the accompanying discussion below of how these non-GAAP financial measures are calc...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
07.05.25 - 22:18
|
Cross Country Healthcare Announces First Quarter 2025 Financial Results (Business Wire)
|
|
|
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the Company) (Nasdaq: CCRN) today announced financial results for its first quarter ended March 31, 2025.
SELECTED FINANCIAL INFORMATION:
Variance
Variance
Q1 2025 vs
Q1 2025 vs
Dollars are in thousands, except per share amounts
Q1 2025
Q1 2024
Q4 2024
Revenue
$
293,408
(23
)
%
(5
)
%
Gross profit margin*
20.0
%
(40
)
bps
—
bps
Net loss attributable to common stockholders
$
(490
)
(118
)
%
87
%
Diluted EPS
$
(0.02
)
$
(0.10
)
$
0.10
Adjusted EBITDA*
$
8,619
(44
)
%
(7
)
%
Adjusted EBITDA margin*
2.9
%
(110
)
bps
(10
)
bps
Adjusted EPS*
$
0.06
$
(0.13
)
$
0.02
Cash flows provided by operations
$
5,681
(5
)
%
(77
)
%
* Represents amounts that are not calculated in accordance with U.S. generally accepted accounting principles (GAAP) and are referred to as non-GAAP measures. Please refer to the accompanying discussion b...
|
|
|
|
|
|
|
|
|
|
|
05.03.25 - 22:18
|
Cross Country Healthcare Announces Fourth Quarter and Full Year 2024 Financial Results (Business Wire)
|
|
|
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) today announced financial results for its fourth quarter and full year ended December 31, 2024.
SELECTED FINANCIAL INFORMATION:
Dollars are in thousands, except per share amounts
Q4 2024
Variance Q4 2024
vs Q4 2023
Variance Q4 2024
vs Q3 2024
Full Year 2024
Variance 2024
vs 2023
Revenue
$
309,940
(25
)
%
(2
)
%
$
1,344,004
(33
)
%
Gross profit margin*
20.0
%
(190
)
bps
(40
)
bps
20.4
%
(190
)
bps
Net loss attributable to common stockholders
$
(3,753
)
(142
)
%
(247
)
%
$
(14,556
)
(120
)
%
Diluted EPS
$
(0.12
)
$
(0.38
)
$
(0.20
)
$
(0.44
)
$
(2.49
)
Adjusted EBITDA*
$
9,271
(55
)
%
(10
)
%
$
49,073
(66
)
%
Adjusted EBITDA margin*
3.0
%
(200
)
bps
(30
)
bps
3.7
%
(350
)
bps
Adjusted EPS*
$
0.04
$
(0.25
)
$
(0.08
)
$
0.46
$
(1.77
)
Cash flows provided by operations
$
24,2...
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
